|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | |
| A61P 25/14 | |||
| A61P 25/16 |
| (11) | Number of the document | 2480228 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10762629.3 |
| Date of filing the European patent application | 2010-09-22 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/063946 |
| Date | 2010-09-22 |
| (87) | Number | WO 2011/036167 |
| Date | 2011-03-31 |
| (30) | Number | Date | Country code |
| 244658 P | 2009-09-22 | US |
| (72) |
DI PAOLO, Thérčse, CA
FEUERBACH, Dominik, CH
GOMEZ-MANCILLA, Baltazar, CH
JOHNS, Donald, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS |
| USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS |